Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)

SHA:603102 Revenue

Weihai Baihe Biology Technological had revenue of 251.64M CNY in the quarter ending June 30, 2026, with 17.96% growth. This brings the company's total for the last twelve months to 994.19M, up 22.76% year-over-year. In the year 2025, Weihai Baihe Biology Technological had annual revenue of 910.93M with 13.67% growth. That makes Weihai Baihe Biology Technological the 19,668th largest company in the world by revenue and 3,606th in China.

• Revenue (ttm): 994.19M
• Revenue Growth: +22.76%
• P/S Ratio: 2.10
• Revenue / Employee: 907.11K
• Employees: 1,096
• Market Cap: 2.09B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Soft Capsule 287.44M 31.8%
• Functional Drink 276.24M 30.6%
• Powder 129.87M 14.4%
• Tablet 84.35M 9.3%
• Hard Capsules 78.43M 8.7%
• Fondant 45.62M 5.1%
• Combinations and Others 1.46M 0.2%

By Geography

Chart

• China 792.19M 87.7%
• Overseas 111.23M 12.3%

Fiscal year ended Dec 31, 2025 See the full SHA:603102 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	910.93M	109.53M	13.67%
Dec 31, 2024	801.40M	-69.85M	-8.02%
Dec 31, 2023	871.25M	145.93M	20.12%
Dec 31, 2022	725.33M	63.45M	9.59%
Dec 31, 2021	661.87M	83.59M	14.45%

Data Source: S&P Global Market Intelligence Last updated: Aug 9, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error